TY  - JOUR
AU  - Escamilla-Gomez, Virginia
AU  - Garcia-Gutierrez, Valentin
AU  - Lopez-Corral, Lucia
AU  - Garcia-Cadenas, Irene
AU  - Perez-Martinez, Ariadna
AU  - Marquez-Malaver, Francisco J
AU  - Caballero-Velazquez, Teresa
AU  - Gonzalez-Sierra, Pedro A
AU  - Viguria-Alegria, Maria C
AU  - Parra-Salinas, Ingrid M
AU  - Calderon-Cabrera, Cristina
AU  - Gonzalez-Vicent, Marta
AU  - Rodriguez-Torres, Nancy
AU  - Parody-Porras, Rocio
AU  - Ferra-Coll, Christelle
AU  - Orti, Guillermo
AU  - Valcarcel-Ferreiras, David
AU  - De-la-Camara-LLanza, Rafael
AU  - Moles, Paula
AU  - Velazquez-Kennedy, Kyra
AU  - João-Mende, Maria
AU  - Caballero-Barrigon, Dolores
AU  - Perez, Estefania
AU  - Martino-Bofarull, Rodrigo
AU  - Saavedra-Gerosa, Silvanna
AU  - Sierra, Jorge
AU  - Poch, Marc
AU  - Zudaire-Ripa, Maria T
AU  - Diaz-Perez, Miguel A
AU  - Molina-Angulo, Blanca
AU  - Sanchez-Ortega, Isabel
AU  - Sanz-Caballer, Jaime
AU  - Montoro-Gomez, Juan
AU  - Espigado-Tocino, Ildefonso
AU  - Perez-Simon, Jose A
PY  - 2020
DO  - 10.1038/s41409-019-0731-x
UR  - http://hdl.handle.net/10668/14653
T2  - Bone marrow transplantation
AB  - Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. First-line treatment is based on the use of high doses of corticosteroids. Unfortunately, second-line treatment for both...
LA  - en
PB  - Nature Publishing Group
KW  - Drug development
KW  - Molecularly targeted therapy
KW  - Acute Disease
KW  - Hematopoietic Stem Cell Transplantation
KW  - Pyrazoles
KW  - Chronic Disease
KW  - Graft vs Host Disease
KW  - Humans
KW  - Nitriles
KW  - Pyrimidines
KW  - Retrospective Studies
TI  - Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.
TY  - research article
VL  - 55
ER  -